2
Participants
Start Date
December 1, 2025
Primary Completion Date
October 31, 2028
Study Completion Date
October 31, 2028
Device Implantation- Boston Scientific, VERCISE GENUS™ system
Participants will be implanted with DBS leads bilaterally, targeting the Nucleus Basalis of Meynert. The study team will record Local Field Potentials with and without stimulation, intraoperatively. These results will help the team determine at the end of the study whether LFP desynchronization (decrease in 5-15 Hz power), or other physiological signature, can be used to predict the location that provides the most effective intervention. Finally, the team will also ascertain the safety of the procedure and NB stimulation itself.
DBS Stimulation - Boston Scientific, VERCISE GENUS™ system
Daily intermittent stimulation (60 Hz x 20s/min)
Vanderbilt Medical Center, Nashville
Collaborators (1)
Boston Scientific Corporation
INDUSTRY
Vanderbilt University Medical Center
OTHER